How Abuse Deterrent Reformulated Opioids Can Stop A Costly Problem Diversion
How Abuse-Deterrent Reformulated Opioids Can Stop a Costly Problem: Diversion
In this presentation, Dan Cohen, Executive Vice President, Government & Public Relations, presents on:
Why you should invest in ADFs and the investments made so far
Understanding how ADFs are effective in reducing the diversion of pharmaceutical products
Comparing recent data on drug abuse and diversion before and after formulation
Learning from law enforcement to round out your pharmaceutical landscape
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.